|
Volumn 61, Issue 8, 2012, Pages 1349-1353
|
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, Denmark
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
CHIMERIC ANTIGEN RECEPTOR;
CYCLOPHOSPHAMIDE;
DENDRITIC CELL VACCINE;
DIPHTHERIA PERTUSSIS TETANUS VACCINE;
DNA VACCINE;
DOXORUBICIN;
LYMPHOCYTE ANTIGEN RECEPTOR;
PLACEBO;
RACOTUMOMAB;
TEMOZOLOMIDE;
TRANSCRIPTION FACTOR E2F1;
UNCLASSIFIED DRUG;
ADOPTIVE IMMUNOTHERAPY;
ADOPTIVE TRANSFER;
ANTIGEN RECOGNITION;
BREAST CANCER;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CANCER PROGNOSIS;
CHRONIC MYELOID LEUKEMIA;
CONFERENCE PAPER;
DENMARK;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG SAFETY;
GLIOBLASTOMA;
HUMAN;
IMMUNOLOGICAL MONITORING;
IMMUNOSTIMULATION;
LOW DRUG DOSE;
LUNG METASTASIS;
LUNG NON SMALL CELL CANCER;
LYMPHOCYTE FUNCTION;
MELANOMA;
NONHUMAN;
PRIORITY JOURNAL;
SUPPRESSOR CELL;
T LYMPHOCYTE;
TREATMENT OUTCOME;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR ESCAPE;
ANIMALS;
CANCER VACCINES;
DENMARK;
HUMANS;
IMMUNOTHERAPY;
|
EID: 84865792800
PISSN: 03407004
EISSN: 14320851
Source Type: Journal
DOI: 10.1007/s00262-012-1209-5 Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|